Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
Lamers
Cor H J
CH
Sleijfer
Stefan
S
Vulto
Arnold G
AG
Kruit
Wim H J
WH
Kliffen
Mike
M
Debets
Reno
R
Gratama
Jan W
JW
Stoter
Gerrit
G
Oosterwijk
Egbert
E
D019264:Adoptive Transfer; D000911:Antibodies, Monoclonal / Q000235:genetics*; D000951:Antigens, Neoplasm / Q000276:immunology*; D000071231:Carbonic Anhydrase IX; D002256:Carbonic Anhydrases / Q000276:immunology*; D002292:Carcinoma, Renal Cell / Q000201:enzymology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007128:Immunoglobulin Fragments / Q000235:genetics*; D007680:Kidney Neoplasms / Q000201:enzymology / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D013601:T-Lymphocytes / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D007128:Immunoglobulin Fragments; C055966:immunoglobulin Fv; C089226:CA9 protein, human; D000071231:Carbonic Anhydrase IX; D002256:Carbonic Anhydrases